Physiomics (LON:PYC) Shares Up 15.3% – Still a Buy?

Physiomics Plc (LON:PYCGet Free Report)’s stock price was up 15.3% during trading on Friday . The company traded as high as GBX 0.49 and last traded at GBX 0.49. Approximately 11,489,002 shares were traded during mid-day trading, an increase of 67% from the average session volume of 6,890,543 shares. The stock had previously closed at GBX 0.42.

Physiomics Trading Up 15.3%

The firm has a market cap of £2.22 million, a P/E ratio of -3.27 and a beta of 1.05. The firm has a 50-day simple moving average of GBX 0.55 and a 200-day simple moving average of GBX 0.47.

Physiomics Company Profile

(Get Free Report)

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

Further Reading

Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.